Literature DB >> 27245021

[Incidence rate of adverse reaction/event by Qingkailing injection: a Meta-analysis of single rate].

Chun-ling Ai, Yan-ming Xie, Ming-quan Li, Lian-xin Wang, Xing Liao.   

Abstract

To systematically review the incidence rate of adverse drug reaction/event by Qingkailing injection. Such databases as the PubMed, EMbase, the Cochrane library, CNKI, VIP WanFang data and CBM were searched by computer from foundation to July 30, 2015. Two reviewers independently screened literature according to the inclusion and exclusion criteria, extracted data and cross check data. Then, Meta-analysis was performed by using the R 3.2.0 software, subgroup sensitivity analysis was performed based on age, mode of medicine, observation time and research quality. Sixty-three studies involving 9,793 patients with Qingkailing injection were included, 367 cases of adverse reactions/events were reported in total. The incidence rate of adverse reaction in skin and mucosa group was 2% [95% CI (0.02; 0.03)]; the digestive system adverse reaction was 6% [95% CI(0.05; 0.07); the injection site adverse reaction was 4% [95% CI (0.02; 0.07)]. In the digestive system as the main types of adverse reactions/events, incidence of children and adults were 4.6% [0.021 1; 0.097 7] and 6.9% [0.053 5; 0.089 8], respectively. Adverse reactions to skin and mucous membrane damage as the main performance/event type, the observation time > 7 days and ≤ 7 days incidence of 3% [0.012 9; 0.068 3] and 1.9% [0.007 8; 0.046 1], respectively. Subgroup analysis showed that different types of adverse reactions, combination in the incidence of adverse reactions/events were higher than that of single drug, the difference was statistically significant (P < 0.05). This study suggested the influence factors of adverse reactions occur, and clinical rational drug use, such as combination, age and other fators, and the influence factors vary in different populations. Therefore, clinical doctors for children and the elderly use special care was required for a clear and open spirit injection, the implementation of individualized medication.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 27245021

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

1.  Reevaluation of the post-marketing safety of Shuxuening injection based on real-world and evidence-based evaluations.

Authors:  Can Wang; Qing-Ping Shi; Feng Ding; Xiao-Dong Jiang; Wei Tang; Mei-Ling Yu; Jian-Hua Zhu
Journal:  Drug Des Devel Ther       Date:  2018-04-05       Impact factor: 4.162

2.  Chlorogenic acid in the oxidative stress injury triggered by Shuang-Huang-Lian injection.

Authors:  Wen-Yuan Du; Ying Xiao; Jian-Jing Yao; Zhe Hao; Yu-Bin Zhao
Journal:  Exp Ther Med       Date:  2018-08-02       Impact factor: 2.447

3.  Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis.

Authors:  Shi-Yuan Wang; Jin-Fang Sun; Pei Liu; Li Luo; Jing-Xin Li; Feng-Cai Zhu; Xu-Xiang Shen; Fan-Yue Meng
Journal:  Hum Vaccin Immunother       Date:  2022-02-22       Impact factor: 3.452

Review 4.  Adverse Effects of Andrographolide Derivative Medications Compared to the Safe use of Herbal Preparations of Andrographis paniculata: Results of a Systematic Review and Meta-Analysis of Clinical Studies.

Authors:  Ya-Xi Shang; Chen Shen; Trine Stub; Si-Jia Zhu; Shu-Yu Qiao; Yu-Qi Li; Rui-Ting Wang; Jing Li; Jian-Ping Liu
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.